Fred Hutchinson Cancer Research Center (Fred Hutch), home of three Nobel laureates, is an independent, nonprofit research institution dedicated to the development and advancement of biomedical research to eliminate cancer and other potentially fatal diseases. Recognized internationally for its pioneering work in bone-marrow transplantation, Fred Hutch's five scientific divisions collaborate to form a unique environment for conducting basic and applied science. The Fred Hutch, in collaboration with its clinical and research partners, the University of Washington and Seattle Children's, is the only National Cancer Institute-designated comprehensive cancer center in the Pacific Northwest.
The Fred Hutchinson Cancer Research Center is delighted to request applications for the 2016 inaugural CTI BioPharma International Postdoctoral Research Fellowship, which is an endowed visiting fellowship in translational science with an emphasis on hematologic malignancies. This fellowship is intended to foster stronger international collaborations in translational research in blood-related cancers and immunobiology.
This fellowship opportunity is intended to support visiting physician-scientists interested in performing research in the Clinical Research Division of the Fred Hutchinson Cancer Research Center, and to foster international collaboration in translational research investigating hematologic malignancies or immunobiology. Visiting physician-scientists will be appointed for one-year terms, which can be renewed. Preference will be given to foreign physician-scientists.
Suitable applicants should hold an MD, PhD or MD/PhD degree. Research interest in translational science with an emphasis on hematologic malignancies.
Application Deadline: Jan. 10, 2016
If interested, please apply online at http://track.tmpservice.com/ApplyClick.aspx?id=2332775-2647-7921